COVID-19
view channel
view channel
Medical Imaging
AICritical CareSurgical TechniquesWomen's HealthPatient CareHealth ITBusiness
- Siemens Reportedly Considering Sale of Its Ultrasound Business
- Zoll Medical Acquires CSA Systems Manufacturer Respicardia
- Rapid AI Penetration to Drive Growth of Global MR Vital Sign Monitors Market
- Machine Learning Algorithm Identifies Deteriorating Patients in Hospital Who Need Intensive Care
- AI-Based ICU Solution for Predicting Patient Deterioration Becomes Industry’s First Ever Device to Receive FDA Clearance
- Adding Artificial Intelligence (AI) System to Breast Ultrasound Can Reduce Unnecessary Biopsies, Finds Study
- Wound Telehealth Assessment System Monitors Healing Data
- Tracker App Reveals Six Types of COVID-19 Infection
- AI-Powered Reading Increases Mammography Accuracy
- Smart Fever and Contact Tracing System Helps Businesses Reopen
COVID-19
- Siemens Reportedly Considering Sale of Its Ultrasound Business
- Zoll Medical Acquires CSA Systems Manufacturer Respicardia
- Rapid AI Penetration to Drive Growth of Global MR Vital Sign Monitors Market
- Machine Learning Algorithm Identifies Deteriorating Patients in Hospital Who Need Intensive Care
- AI-Based ICU Solution for Predicting Patient Deterioration Becomes Industry’s First Ever Device to Receive FDA Clearance
- Adding Artificial Intelligence (AI) System to Breast Ultrasound Can Reduce Unnecessary Biopsies, Finds Study
- Wound Telehealth Assessment System Monitors Healing Data
- Tracker App Reveals Six Types of COVID-19 Infection
- AI-Powered Reading Increases Mammography Accuracy
- Smart Fever and Contact Tracing System Helps Businesses Reopen
- AI-Enhanced EKG Can Be Used as Rapid, Reliable COVID-19 Screening Test to Rule out Infection
- Getinge's AI Solution Helps Hospitals Address Post COVID-19 Pandemic Surgical Backlog
- Oral COVID-19 Vaccine Proves an Effective Booster in Preclinical Trial
- Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 and Its Variants than Current Antibody Therapies
- Experimental Drug TEMPOL May Be Promising Oral Antiviral Treatment for COVID-19, Suggests New Research
Client Login